171 related articles for article (PubMed ID: 12496253)
21. Activation of human factor IX (Christmas factor).
Di Scipio RG; Kurachi K; Davie EW
J Clin Invest; 1978 Jun; 61(6):1528-38. PubMed ID: 659613
[TBL] [Abstract][Full Text] [Related]
22. Structural requirements for Ca2+ binding to the gamma-carboxyglutamic acid and epidermal growth factor-like regions of factor IX. Studies using intact domains isolated from controlled proteolytic digests of bovine factor IX.
Astermark J; Björk I; Ohlin AK; Stenflo J
J Biol Chem; 1991 Feb; 266(4):2430-7. PubMed ID: 1989994
[TBL] [Abstract][Full Text] [Related]
23. A human antibody that binds to the gamma-carboxyglutamic acid domain of factor IX is a potent antithrombotic in vivo.
Refino CJ; Himber J; Burcklen L; Moran P; Peek M; Suggett S; Devaux B; Kirchhofer D
Thromb Haemost; 1999 Sep; 82(3):1188-95. PubMed ID: 10494786
[TBL] [Abstract][Full Text] [Related]
24. Blood clotting factor IX Nagoya 3: the molecular defect of zymogen activation caused by an arginine-145 to histidine substitution.
Suehiro K; Miyata T; Takeya H; Takamatsu J; Saito H; Murakawa M; Okamura T; Niho Y; Iwanaga S
Thromb Res; 1990 Nov; 60(4):311-20. PubMed ID: 2087690
[TBL] [Abstract][Full Text] [Related]
25. Substitution of the Gla domain in factor X with that of protein C impairs its interaction with factor VIIa/tissue factor: lack of comparable effect by similar substitution in factor IX.
Ndonwi M; Broze GJ; Agah S; Schmidt AE; Bajaj SP
J Biol Chem; 2007 May; 282(21):15632-44. PubMed ID: 17387172
[TBL] [Abstract][Full Text] [Related]
26. Factor IX activation by factor XIa proceeds without release of a free intermediate.
Wolberg AS; Morris DP; Stafford DW
Biochemistry; 1997 Apr; 36(14):4074-9. PubMed ID: 9100000
[TBL] [Abstract][Full Text] [Related]
27. An Arg/Ser substitution in the second epidermal growth factor-like module of factor IX introduces an O-linked carbohydrate and markedly impairs activation by factor XIa and factor VIIa/Tissue factor and catalytic efficiency of factor IXa.
Hertzberg MS; Facey SL; Hogg PJ
Blood; 1999 Jul; 94(1):156-63. PubMed ID: 10381508
[TBL] [Abstract][Full Text] [Related]
28. The epidermal growth factor-like domains of factor IX. Effect on blood clotting and endothelial cell binding of a fragment containing the epidermal growth factor-like domains linked to the gamma-carboxyglutamic acid region.
Astermark J; Stenflo J
J Biol Chem; 1991 Feb; 266(4):2438-43. PubMed ID: 1989995
[TBL] [Abstract][Full Text] [Related]
29. Effects of gamma-carboxyglutamic acid and epidermal growth factor-like modules of factor IX on factor X activation. Studies using proteolytic fragments of bovine factor IX.
Astermark J; Hogg PJ; Björk I; Stenflo J
J Biol Chem; 1992 Feb; 267(5):3249-56. PubMed ID: 1737781
[TBL] [Abstract][Full Text] [Related]
30. Factor IX Zutphen: a Cys18-->Arg mutation results in formation of a heterodimer with alpha 1-microglobulin and the inability to form a calcium-induced conformation.
Wojcik EG; van den Berg M; van der Linden IK; Poort SR; Cupers R; Bertina RM
Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):753-9. PubMed ID: 7487929
[TBL] [Abstract][Full Text] [Related]
31. The factor IX phospholipid-binding site is required for calcium-dependent activation of factor IX by factor XIa.
Liebman HA; Furie BC; Furie B
J Biol Chem; 1987 Jun; 262(16):7605-12. PubMed ID: 3108254
[TBL] [Abstract][Full Text] [Related]
32. Derivatives of blood coagulation factor IX contain a high affinity Ca2+-binding site that lacks gamma-carboxyglutamic acid.
Morita T; Isaacs BS; Esmon CT; Johnson AE
J Biol Chem; 1984 May; 259(9):5698-704. PubMed ID: 6425296
[TBL] [Abstract][Full Text] [Related]
33. Snake-venom-derived Factor IX-binding protein specifically blocks the gamma-carboxyglutamic acid-rich-domain-mediated membrane binding of human Factors IX and X.
Gopinath SC; Shikamoto Y; Mizuno H; Kumar PK
Biochem J; 2007 Jul; 405(2):351-7. PubMed ID: 17407444
[TBL] [Abstract][Full Text] [Related]
34. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
[TBL] [Abstract][Full Text] [Related]
35. Molecular defect in factor IX Tokyo: substitution of valine-182 by alanine at position P2' in the second cleavage site by factor XIa resulting in impaired activation.
Maekawa H; Sugo T; Yamashita N; Kamiya K; Umeyama H; Miura N; Naka H; Nishimura T; Yoshioka A; Matsuda M
Biochemistry; 1993 Jun; 32(24):6146-51. PubMed ID: 8512923
[TBL] [Abstract][Full Text] [Related]
36. Structure of the calcium ion-bound gamma-carboxyglutamic acid-rich domain of factor IX.
Freedman SJ; Furie BC; Furie B; Baleja JD
Biochemistry; 1995 Sep; 34(38):12126-37. PubMed ID: 7547952
[TBL] [Abstract][Full Text] [Related]
37. Characterization of factor VII association with tissue factor in solution. High and low affinity calcium binding sites in factor VII contribute to functionally distinct interactions.
Ruf W; Kalnik MW; Lund-Hansen T; Edgington TS
J Biol Chem; 1991 Aug; 266(24):15719-25. PubMed ID: 1874730
[TBL] [Abstract][Full Text] [Related]
38. Mutations in hemophilia Bm occur at the Arg180-Val activation site or in the catalytic domain of factor IX.
Bertina RM; van der Linden IK; Mannucci PM; Reinalda-Poot HH; Cupers R; Poort SR; Reitsma PH
J Biol Chem; 1990 Jul; 265(19):10876-83. PubMed ID: 2162822
[TBL] [Abstract][Full Text] [Related]
39. Binding of the factor IX gamma-carboxyglutamic acid domain to the vitamin K-dependent gamma-glutamyl carboxylase active site induces an allosteric effect that may ensure processive carboxylation and regulate the release of carboxylated product.
Lin PJ; Straight DL; Stafford DW
J Biol Chem; 2004 Feb; 279(8):6560-6. PubMed ID: 14660587
[TBL] [Abstract][Full Text] [Related]
40. Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity.
Perot E; Enjolras N; Le Quellec S; Indalecio A; Girard J; Negrier C; Dargaud Y
Thromb Res; 2015 May; 135(5):1017-24. PubMed ID: 25795563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
